Literature DB >> 6504866

The economic costs of smoking and benefits of quitting for individual smokers.

G Oster, G A Colditz, N L Kelly.   

Abstract

The results of a study that estimated the expected lifetime economic consequences of cigarette smoking for individual smokers are reported herein. The estimates were obtained by combining age- and sex-specific estimates of the incidence-based costs of three smoking-related diseases (lung cancer, coronary heart disease, and emphysema) with estimates of smokers' increased likelihood of developing these illnesses in each remaining year of life relative to nonsmokers. Estimates of the economic consequences of quitting based on these disease cost estimates and on estimates of exsmokers' probability of future disease relative to continuing smokers are also reported. Both the estimates of the economic costs of smoking and the benefits of quitting were calculated separately for men and women between the ages of 35 and 79 who were light, moderate, or heavy cigarette smokers. While the economic costs of smoking varied considerably by sex, age, and amount smoked, they were significant for all groups of smokers. Costs for a 40-year-old man, for example, ranged from $20,000 for a smoker of less than one pack of cigarettes per day to over $56,000 for a smoker of more than two packs of cigarettes per day. The economic benefits of quitting also were found to be sizable for all groups of smokers.

Entities:  

Mesh:

Year:  1984        PMID: 6504866     DOI: 10.1016/0091-7435(84)90029-x

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  14 in total

Review 1.  Medical costs of smoking in the United States: estimates, their validity, and their implications.

Authors:  K E Warner; T A Hodgson; C E Carroll
Journal:  Tob Control       Date:  1999       Impact factor: 7.552

2.  If smoking increases absences, does quitting reduce them?

Authors:  J L Sindelar; N Duchovny; T A Falba; S H Busch
Journal:  Tob Control       Date:  2005-04       Impact factor: 7.552

3.  Integrating individual and public health perspectives for treatment of tobacco dependence under managed health care: a combined stepped-care and matching model.

Authors:  D B Abrams; C T Orleans; R S Niaura; M G Goldstein; J O Prochaska; W Velicer
Journal:  Ann Behav Med       Date:  1996

4.  Costs and effects associated with a community pharmacy-based smoking-cessation programme.

Authors:  G E Crealey; J C McElnay; T A Maguire; C O'Neill
Journal:  Pharmacoeconomics       Date:  1998-09       Impact factor: 4.981

5.  A randomized controlled trial of a smoking cessation self-help intervention for dual users of tobacco cigarettes and E-cigarettes: Intervention development and research design.

Authors:  Lauren R Meltzer; Vani N Simmons; Steven K Sutton; David J Drobes; Gwendolyn P Quinn; Cathy D Meade; Marina Unrod; Karen O Brandon; Paul T Harrell; Thomas Eissenberg; Christopher R Bullen; Thomas H Brandon
Journal:  Contemp Clin Trials       Date:  2017-06-22       Impact factor: 2.226

6.  Lifetime health and economic benefits of weight loss among obese persons.

Authors:  G Oster; D Thompson; J Edelsberg; A P Bird; G A Colditz
Journal:  Am J Public Health       Date:  1999-10       Impact factor: 9.308

7.  Economic costs of cigarette smoking among adolescents in Nigeria.

Authors:  Adesola O Olumide; Amir Shmueli; Emmanuel S Adebayo; Olayemi O Omotade
Journal:  Z Gesundh Wiss       Date:  2021-10-27

8.  Impact of baseline weight on smoking cessation and weight gain in quitlines.

Authors:  Terry M Bush; Michele D Levine; Brooke Magnusson; Yu Cheng; Xiaotian Chen; Lisa Mahoney; Lyndsay Miles; Susan M Zbikowski
Journal:  Ann Behav Med       Date:  2014-04

Review 9.  The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.

Authors:  Victor U Ekpu; Abraham K Brown
Journal:  Tob Use Insights       Date:  2015-07-14

10.  Mobile contingency management for smoking cessation among socioeconomically disadvantaged adults: Protocol for a randomized trial.

Authors:  Darla E Kendzor; Michael S Businelle; Damon J Vidrine; Summer G Frank-Pearce; Ya-Chen Tina Shih; Jesse Dallery; Adam C Alexander; Laili Kharazi Boozary; Joseph J C Waring; Sarah J Ehlke
Journal:  Contemp Clin Trials       Date:  2022-01-31       Impact factor: 2.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.